Glaukos Corporation Security Rating

Glaukos is an ophthalmic medical technology and pharmaceutical company that develops therapies for treating glaucoma, corneal disorders, and retinal diseases. It offers various products including iStent inject W, a tool for use in conjunction with cataract surgery for the reduction of intraocular pressure (IOP) in adult patients with mild to moderate primary open-angle glaucoma; iStent infinite, an implantable device intended to reduce IOP of the eye; iAccess Precision Blade; which minimizes tissue disruption and is designed to preserve the eye’s natural blood-aqueous barrier; etc. The company also provides iLink Corneal Cross-Linking, a therapy that creates corneal collagen cross-links, shortens and thickens collagen fibrils, and stiffens the cornea.